Leukemia (DC 7703)

Rating levels

• 100% — You qualify for this rating when your leukemia (blood cancer) is currently active and spreading, or when you're actively receiving treatment like chemotherapy, radiation, or other medical therapies. This covers any period where the cancer is not in remission (not under control) or you're undergoing medical treatment to fight the disease.
• 0% — You qualify under this criteria if you have chronic lymphocytic leukemia (a slow-growing blood cancer where white blood cells build up in your blood and lymph nodes) or monoclonal B-cell lymphocytosis (an early condition that may lead to leukemia), but you have no symptoms at all and your condition is classified as Rai Stage 0 (the earliest, mildest stage where you only have too many white blood cells in your blood but no other problems).
• -1% — The 100% rating for leukemia continues for six months after all treatment ends — chemotherapy, radiation, surgery, immunotherapy, targeted therapy (e.g., tyrosine-kinase inhibitors), or stem-cell / bone-marrow transplant. At the six-month mark, VA must schedule a mandatory examination. If the leukemia has not recurred, the rating is based on residuals — chemotherapy-induced neuropathy (DCs 8520-8540 depending on nerve), cardiomyopathy or congestive heart failure from anthracyclines (DC 7020), fatigue (no separate DC, considered in functional impact), secondary malignancy, persistent cytopenias requiring transfusion or growth-factor support, infection susceptibility, chronic graft-versus-host disease after transplant (rated under affected body systems), and psychiatric residuals. Any reduction in the 100% rating is protected by the due-process requirements of 38 CFR § 3.105(e) — VA must notify you 60 days before reduction with reasons and your right to a hearing. If the leukemia recurs at any time, the 100% rating resumes from the date of recurrence and the six-month clock resets after treatment ends again.